Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

The study’s findings highlight a potential risk factor for younger women with asthma considering their contraceptive options ...

Asthma, a chronic respiratory disease affecting over 262 million people globally, poses a significant public health challenge ...

Imperial College London researchers say they may have found a crucial ‘piece to the puzzle’ why asthma is worse for women and ...

India reportedly has the highest asthma-related deaths in the world, accounting for nearly 46% of them. With over 34 million ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

A major study of around 260,000 women shows that taking the progesterone-only contraceptive pill can increase asthma attacks ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...

Younger women with asthma who take the mini pill may be at a higher risk of potentially life-threatening asthma attacks, a new study suggests. Researchers from Imperial College London found that ...

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...